window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : January 24, 2026

  • News
  • About Us
Contact Us

Hematology

  • Biotech,Clinical Development,Drug Development,European biotech,Hematology,Research & Development,Respiratory

    Cereno Scientific publishes first peer-reviewed data on HDAC inhibitor CS014 showing antithrombotic effects without bleeding risk

    Cereno Scientific has published the first peer-reviewed paper describing its [...]

    January 16, 2026
  • Biologics & Biosimilars,Hematology,Pharmaceuticals and therapeutics

    Grifols fibrinogen concentrate FESILTY approved in the US for acute bleeding in congenital fibrinogen deficiency

    Grifols has received US Food and Drug Administration (FDA) approval [...]

    January 2, 2026
  • Diagnostics,Hematology,Medical devices,Partnerships & Funding

    Appleton blood centre adopts Reveos automation to boost platelet supply

    The Community Blood Center (CBC) in Appleton, Wisconsin has adopted [...]

    December 12, 2025
  • Cell & Gene Therapy,Clinical studies,Clinical Trials,Events and Conferences,Hematology,Oncology,Pharmaceuticals and therapeutics

    CytoAgents to present new CTO1681 clinical safety data at ASH annual meeting

    CytoAgents will present new clinical safety data for CTO1681 at [...]

    December 3, 2025
  • Chronic diseases,Hematology,Pharmaceuticals and therapeutics,Regulatory Affairs

    Grifols secures expanded FDA label for Thrombate to include pediatric hereditary antithrombin deficiency

    Grifols has received US FDA approval for an expanded indication [...]

    November 18, 2025
  • Clinical Development,Clinical Trials,Drug approval,Hematology,Oncology,Pharmaceuticals and therapeutics

    Talquetamab recommended by NICE for relapsed and refractory multiple myeloma

    The National Institute for Health and Care Excellence (NICE) has [...]

    November 17, 2025
  • Biologics & Biosimilars,Drug approval,European biotech,Hematology,Rare Diseases

    Grifols’ Biotest secures first approval for fibrinogen concentrate in Germany

    Grifols’ Biotest has received its first regulatory approval for a [...]

    November 14, 2025
  • Biologics & Biosimilars,Clinical Development,European biotech,Global health,Hematology,Rare Diseases,Technology and platforms

    Terumo BCT and Hemex Health join forces to improve outcomes for sickle cell patients

    Terumo Blood and Cell Technologies (Terumo BCT), a global medical [...]

    October 10, 2025

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • MaaT Pharma randomizes first patient in IMMUNOLIFE Phase 2 NSCLC microbiome study
    Categories: Uncategorised
  • Datwyler, LTS Device Technologies, and Stevanato Group collaborate on large-volume self-administration solutions
    Categories: Biologics & Biosimilars, Drug Delivery & Formulation, Medical devices, Patient Centricity, Pharmaceuticals and therapeutics
  • NeuroVice seizure oral injury device now available through BlinkRx
    Categories: Central Nervous System, Digital Health, Medical devices, Patient Centricity, Pharmaceuticals and therapeutics
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top